ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.15
+0.10 (0.33%)
At close: Sep 1, 2026, 4:00 PM EDT
30.01
-0.14 (-0.46%)
Pre-market: Sep 2, 2026, 7:35 AM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.49 billion as of September 2, 2026. Its market cap has increased by 91.66% in one year.
Market Cap
1.49B
Enterprise Value
1.11B
1-Year Change
91.66%
Ranking
Category
Stock Price
$30.15
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.49B, an increase of 158.45%. That is a compound annual growth rate of 44.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.49B | 78.99% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.55B |
| Avalyn Pharma | 1.54B |
| Bicara Therapeutics | 1.53B |
| LB Pharmaceuticals | 1.52B |
| Innoviva | 1.50B |
| First Tracks Biotherapeutics | 1.49B |
| Tyra Biosciences | 1.49B |
| Maze Therapeutics | 1.48B |